Literature DB >> 10047619

Characteristic cardiovascular manifestation in homozygous and heterozygous familial hypercholesterolemia.

A Kawaguchi1, K Miyatake, C Yutani, S Beppu, M Tsushima, T Yamamura, A Yamamoto.   

Abstract

BACKGROUND: The aortic valve dysfunction of patients with homozygous familial hypercholesterolemia (FH) suggests that hypercholesterolemia affects not only coronary arteries but also the aortic valve. We studied the aortic root of patients with homozygous FH and those of patients with heterozygous FH to characterize the premature atherosclerotic lesions by using histopathologic specimens. METHODS AND
RESULTS: The aortic roots of 10 patients with homozygous FH, age 9 to 58 years, were studied by cardiac catheterization with several angiographies. The aortic roots of 39 patients with heterozygous FH under age 60 years were also examined for aortic and mitral valvular functions by color Doppler echocardiography, and 30 normocholesterolemic patients with coronary artery disease were examined as control subjects. In addition, in 22 patients with FH and 20 control subjects, the internal diameter of the aortic annulus and the aortic ridge in cardiac cycles were measured. Of the 10 homozygotes with FH, 8 patients had aortic regurgitation demonstrated by aortography; 3 of them showed significant transvalvular pressure gradients. Stenotic changes of coronary ostia were observed in 8 of the 10 homozygotes with moderate coronary atherosclerosis. Of the 39 heterozygotes with FH, 10 patients had aortic regurgitation shown by Doppler echocardiography, as did only 1 of the 30 control subjects (P <.05). The average diameter and distensibility of the ascending aorta were significantly reduced in the heterozygotes compared with the control subjects. The surgically resected cusp specimens of aortic valves obtained from 1 homozygous and 1 heterozygous patient showed significant thickening of the cusp with foam cell infiltration.
CONCLUSIONS: Premature atherosclerosis in FH had a characteristic distribution, affecting the aortic root dominantly. The involvement of the aortic valve indicating "hypercholesterolemic valvulopathy" was a peculiar feature of FH, especially its homozygous form, but was reminiscent of ubiquitous processes caused by hypercholesterolemia.

Entities:  

Mesh:

Year:  1999        PMID: 10047619     DOI: 10.1016/s0002-8703(99)70485-0

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  16 in total

Review 1.  Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update.

Authors:  Nalini M Rajamannan; Frank J Evans; Elena Aikawa; K Jane Grande-Allen; Linda L Demer; Donald D Heistad; Craig A Simmons; Kristyn S Masters; Patrick Mathieu; Kevin D O'Brien; Frederick J Schoen; Dwight A Towler; Ajit P Yoganathan; Catherine M Otto
Journal:  Circulation       Date:  2011-10-18       Impact factor: 29.690

2.  Fatal myocardial infarction at 4.5 years in a case of homozygous familial hypercholesterolaemia.

Authors:  Matthias Gautschi; Mladen Pavlovic; Jean-Marc Nuoffer
Journal:  JIMD Rep       Date:  2011-09-06

3.  Severe supravalvar aortic stenosis in familial homozygous hypercholesterolemia.

Authors:  G Arora; C D Fraser; D L Kearney; J A Vincent
Journal:  Pediatr Cardiol       Date:  2006 Mar-Apr       Impact factor: 1.655

Review 4.  Lipoprotein apheresis in the management of familial hypercholesterolaemia: historical perspective and recent advances.

Authors:  Claudia Stefanutti; Gilbert R Thompson
Journal:  Curr Atheroscler Rep       Date:  2015-01       Impact factor: 5.113

5.  Low-density lipoprotein apheresis: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-11-01

Review 6.  Causes and histopathology of ascending aortic disease in children and young adults.

Authors:  Deepali Jain; Harry C Dietz; Gretchen L Oswald; Joseph J Maleszewski; Marc K Halushka
Journal:  Cardiovasc Pathol       Date:  2011 Jan-Feb       Impact factor: 2.185

Review 7.  Calcific aortic stenosis: lessons learned from experimental and clinical studies.

Authors:  Nalini M Rajamannan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-11-20       Impact factor: 8.311

8.  NFκB (Nuclear Factor κ-Light-Chain Enhancer of Activated B Cells) Activity Regulates Cell-Type-Specific and Context-Specific Susceptibility to Calcification in the Aortic Valve.

Authors:  Terence Gee; Emily Farrar; Yidong Wang; Bingruo Wu; Kevin Hsu; Bin Zhou; Jonathan Butcher
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-01-02       Impact factor: 8.311

9.  Calcific Aortic Valve Disease: Molecular Mechanisms and Therapeutic Approaches.

Authors:  Daniel Alejandro Lerman; Sai Prasad; Nasri Alotti
Journal:  Eur Cardiol       Date:  2015

10.  Biventricular adaptation to volume overload in mice with aortic regurgitation.

Authors:  Christopher J Berry; Jordan D Miller; KellyAnn McGroary; Daniel R Thedens; Stephen G Young; Donald D Heistad; Robert M Weiss
Journal:  J Cardiovasc Magn Reson       Date:  2009-08-11       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.